Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

ACEi and ARBS in Hypertension and Heart Failure, PDF eBook

ACEi and ARBS in Hypertension and Heart Failure PDF

Edited by Pasquale Perrone Filardi

Part of the Current Cardiovascular Therapy series

PDF

Please note: eBooks can only be purchased with a UK issued credit card and all our eBooks (ePub and PDF) are DRM protected.

Description

The renin angiotensin system is implicated in the progression of atherosclerotic disease as well as of left ventricular dysfunction.

Angiotensin converting enzyme inhibitors and AT1 receptor antagonists have been proven to reduce morbidity and mortality in patients with left ventricular dysfunction or in those at high cardiovascular risk with preserved ventricular function.

This book is intended to summarize evidences and provide a rationale for the appropriate use of RAS antagonists in cardiovascular diseases.

It will be presented as highly practical information on this topic, written in a quick-access, no-nonsense format.

The emphasis will be on a just-the-facts clinical approach, heavy on tabular material, light on dense prose.

The involvement of the ISCP will ensure that the best quality contributors will be involved and establish a consistent approach to each topic in the series and this title is no exception.

It will contain practical illustrations and is designed to improve understand and practical usage of cardiovascular drugs in specific clinical areas.

Information

Information

Also in the Current Cardiovascular Therapy series  |  View all